Critical Path Public Private Partnerships Clinical Trials Optional
Critical Path Public Private Partnerships Clinical Trials Optional is offered by Food and Drug Administration. Max award: $20,000,000. This is a forecast; the deadline is not set yet.
| Opportunity number | FOR-FD-24-012 |
|---|---|
| Agency | Food and Drug Administration |
| Status | Forecasted |
| Posted | Nov 30, 2023 |
| Closes | Not set |
| Award ceiling | $20,000,000 |
| Award floor | $20,000,000 |
| Total program funding | Not specified |
| Expected awards | 1 |
| Who can apply | Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Category | Agriculture, Consumer Protection, Food and Nutrition |
Summary (excerpt)
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act . This includes developing innovative, collaborative projects in research, education, a…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from Food and Drug Administration